Fuquan Liu

Macrophage Sphingosine 1-Phosphate Receptor 2 Blockade Attenuates Liver Inflammation and Fibrogenesis Triggered by NLRP3 Inflammasome

Lei Hou, Le Yang, Na Chang et al. · Frontiers in Immunology · 2020 · 99 citations · Full text

Development and validation of a radiomics signature for clinically significant portal hypertension in cirrhosis (CHESS1701): a prospective multicenter study

Fuquan Liu, Zhenyuan Ning, Yanna Liu et al. · EBioMedicine · 2018 · 92 citations · Full text

Virtual Hepatic Venous Pressure Gradient with CT Angiography (CHESS 1601): A Prospective Multicenter Study for the Noninvasive Diagnosis of Portal Hypertension

Xiaolong Qi, Weimin An, Fuquan Liu et al. · Radiology · 2018 · 61 citations

An imaging-based artificial intelligence model for non-invasive grading of hepatic venous pressure gradient in cirrhotic portal hypertension

Qian Yu, Yifei Huang, Xiaoguo Li et al. · Cell Reports Medicine · 2022 · 34 citations · Full text

Cirrhotic Portal Hypertension, Urology, Engineering +14

Neutrophil recruitment mediated by sphingosine 1-phosphate (S1P)/S1P receptors during chronic liver injury

Xinhao Zhao, Le Yang, Na Chang et al. · Cellular Immunology · 2020 · 32 citations

Inflammation, Hepatology, Liver Physiology +13